Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 18/07/2026 +04			5-day change	1st Jan Change
24.56 ^USD	+6.04%		+6.60%	+56.63%

06-29	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark	CI
06-29	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
MONTE ROSA THERAPEUTICS, INC.	2.07B	-	B	-	-
REVOLUTION MEDICINES, INC.	39.58B	-	B	-	-
BEONE MEDICINES AG	34.69B		-
IQVIA HOLDINGS INC.	34.42B		AAA
CELLTRION, INC.	27.11B		A
ASCENDIS PHARMA A/S	16.21B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.36B		BBB
EUROFINS SCIENTIFIC SE	14.05B		AA
ICON PUBLIC LIMITED COMPANY	13.02B		AAA
ABIVAX	11.76B	-	BBB	-	-
BIO-TECHNE CORPORATION	11.24B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.81B		AA
APOGEE THERAPEUTICS, INC.	10.04B	-	B	-	-
TEMPUS AI, INC.	9.42B		A		-
PHARMARON BEIJING CO., LTD.	8.8B		AA
KYMERA THERAPEUTICS, INC.	9.52B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	8.99B	-	A	-	-
ALKERMES PLC	8.79B		A
PRAXIS PRECISION MEDICINES, INC.	8.77B	-	B	-	-
QIAGEN N.V.	8.51B		AAA
Average	15.16B		A
Weighted average by Cap.			A